Details for New Drug Application (NDA): 020831
✉ Email this page to a colleague
The generic ingredient in FORADIL is formoterol fumarate. There are nineteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the formoterol fumarate profile page.
Summary for 020831
Tradename: | FORADIL |
Applicant: | Novartis |
Ingredient: | formoterol fumarate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020831
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INHALATION | Strength | 0.012MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Feb 16, 2001 | TE: | RLD: | Yes |
Expired US Patents for NDA 020831
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | FORADIL | formoterol fumarate | POWDER;INHALATION | 020831-001 | Feb 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | FORADIL | formoterol fumarate | POWDER;INHALATION | 020831-001 | Feb 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription